Identified two biomarkers in the blood that capture signs of Alzheimer’s disease
An international team led by the “Barcelona Beta Brain Research Center” (BBRC) has found in a study that the plasma biomarkers p-tau231 and p-tau217 are “optimal” to show the first signs of amyloid accumulation in the brain and will help promote clinical trials on the preclinical phase of Alzheimer’s disease. The first two authors of … Read more